Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the Real World by Michael S RitsnerPolypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the Real World by Michael S Ritsner

Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the Real World

byMichael S Ritsner

Paperback | February 8, 2015

Pricing and Purchase Info

$227.75 online 
$275.95 list price save 17%
Earn 1,139 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Title:Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the Real WorldFormat:PaperbackDimensions:321 pagesPublished:February 8, 2015Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9401782563

ISBN - 13:9789401782562

Look for similar items by category:


Table of Contents

About the Editor


Contributors to Volume II

Part 1. Antipsychotic polypharmacy

1. Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'? Peter F. Buckley

2. Antipsychotic polypharmacy in USA. Anand K. Pandurangi, John Vernon

3. Antipsychotic polypharmacy in Czech Republic and in Ukraine. Viktor P. Samokhvalov, Oxana Samokhvalova, Viktoria A. Verbenko, Georgij N. Verbenko

4. Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice. Lucio Ghio, Werner Natta, Simona Gotelli, Luigi Ferrannini

5. Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? KH Yong, Norman Sartorius, Kang Sim

6. Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Masaru Mimura

7. Clozapine combinations in treatment-resistant schizophrenia patients. Vladimir Lerner and Chanoch Miodownik

8. Metabolic syndrome and antipsychotic polypharmacy. Fuminari Misawa, Fujii Yasuo, Yasuyuki Okumura, Hiroto Ito

Part 2. Polypharmacy for other psychiatric conditions

9. Evidence based combination therapy for bipolar disorder. Stamatia Magiria, Melina Siamouli, Xenia Gonda, Apostolos Iacovides, Konstantinos N. Fountoulakis

10. Antidepressant combination strategies for major depressive disorder. André F. Carvalho, Danielle S. Macêdo, Thomas N. Hyphantis, Roger S. McIntyre

11. Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk. Arun V. Ravindran and Tricia L. da Silva

12. Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? Frederike Schirmbeck and Mathias Zink

13. Polypharmacy and potentially inappropriate medication use among elders with dementia. Jan Lužný

14. The role of polypharmacy in bipolar disorder treatment guidelines. Heinz Grunze

Appendix Rena Kurs

1. Annotated bibliography on polypharmacy

2. List of Psychotropic Medications

Contents to Volume I

Contributors to Volume I